Cosmo and Sun Pharma Announce Territory Expansion of License and Supply Agreements for WINLEVI® to i

Cosmo Pharmaceuticals N.V. / Key word(s): Agreement26-Jul-2022 / 06:01 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRDublin, Ireland and Mumbai, India – 26 July 2022: Sun Pharmaceutical In...

Related Keywords

Cranbury ,New South Wales ,Australia ,Japan ,United States ,Brazil ,Zurich ,Züsz ,Switzerland ,Canada ,Russia ,Dublin ,Ireland ,London ,City Of ,United Kingdom ,Mexico ,India ,New Zealand ,Mumbai ,Maharashtra ,American ,Sun Pharma ,Nimish Desai ,Gaurav Chugh ,Clin Aesthet Dermatol ,Diana Harbort ,Hazel Winchester ,Deutsches Eigenkapitalforum ,Falk Gmbh ,Aalok Shanghvi ,Gerlonim Cortexolone ,Bloomberg ,Cosmo Pharmaceuticals ,American Academy Of Dermatology Association ,Sun Pharmaceutical Industries Limited Reuters ,Sun Pharmaceutical Industries Limited ,Drug Administration ,Commerzbank ,Cosmo Pharmaceuticalsnv Key ,Cosmo Dermatology Division ,Credit Suisse Equity Forum Switzerland ,Medtronic ,Red Hill Biopharma Ltd ,Sun Pharmaceutical Industries Inc ,Supply Agreements ,Generic Global ,Emerging Markets ,Red Hill Biopharma ,Del Rosso ,Clin Aesthet ,Dermatology Association ,Accessed September ,Cosmet Investig ,Sun Pharmaceutical Industries ,